Trimazide en es it fr

Trimazide Brand names, Trimazide Analogs

Trimazide Brand Names Mixture

  • Alphasel tablets (calcium phosphate [dibasic] + cobalt sulfate + D-alpha tocopheryl acetate + selenium sulfide)
  • Previte (neomycin sulfate + selenium sulfide + streptomycin sulfate + vitamin A + vitamin D + vitamin E + vitamin K1)

Trimazide Chemical_Formula


Trimazide RX_link

No information avaliable

Trimazide fda sheet

Trimazide msds (material safety sheet)

Trimazide MSDS

Trimazide Synthesis Reference

No information avaliable

Trimazide Molecular Weight

280.285 g/mol

Trimazide Melting Point

No information avaliable

Trimazide H2O Solubility

No information avaliable

Trimazide State


Trimazide LogP


Trimazide Dosage Forms

Intravenous (loading dose of 12 to 24 micrograms/kg over 10 minutes followed by a continuous infusion of 0.05 to 0.2 micrograms/kg per minute, adjusted according to response)

Trimazide Indication

For short term treatment of acutely decompensated severe chronic heart failure (CHF).

Trimazide Pharmacology

Levosimendan is a new Ca2+-sensitizing inotropic agent. Ca2+ sensitizers represent a new class of inotropic agents, which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias, cell injury and death due to Ca2+ overload in myocardial cells; they do not increase the activation energy; and they have the potential to reverse contractile dysfunction under pathophysiologic conditions, such as acidosis or myocardial stunning. Levosimendan has not been approved for use in the U.S. or Canada.

Trimazide Absorption

The bioavailability of oral levosimendan is 85 ± 6% in healthy volunteers and 84 ± 4% in patients.

Trimazide side effects and Toxicity

No information avaliable

Trimazide Patient Information

No information avaliable

Trimazide Organisms Affected

Humans and other mammals